1st Edition

Vaccination Programmes Epidemiology, Monitoring, Evaluation

470 Pages 82 B/W Illustrations
by Routledge

470 Pages 82 B/W Illustrations
by Routledge

470 Pages 82 B/W Illustrations
by Routledge

Vaccination programmes are of vital importance to public health and are present in virtually every country in the world. By promoting an understanding of the diverse effects of vaccination programmes, this textbook discusses how epidemiologic methods can be used to study, in real life, their impacts, benefits and risks. Written by expert practitioners in an accessible and concise style, this... Read more

Part I: Background  1.Vaccines  2.How vaccines work  3.Vaccination programmes  4.Dynamics of controlling vaccine preventable diseases  5.Impact of mass vaccination programmes  6.Vaccine risks: a societal perspective  Part II: Field Tools for Monitoring Vaccination Programmes  7.Monitoring vaccine coverage and attitudes towards vaccination  8.Surveillance of vaccine preventable diseases and pathogens  9.Serological surveillance  10.Assessing impact  11.Outbreak investigation of vaccine preventable diseases  Part III: Vaccine Effectiveness  12.Vaccine effectiveness  13.Estimating vaccine effectiveness: General methodological principles  14.Estimating vaccine effectiveness: Cohort and household contact studies  15.Estimating vaccine effectiveness: Case-control and screening studies  16.Waning vaccine effectiveness and models of vaccine action  Part IV: Risks Associated with Vaccination Programmes  17.Vaccine safety: an introduction  18.Surveillance of adverse events following immunisation  19.Estimating vaccination risks: general methodological principles  20.Epidemiological study designs for evaluating vaccine safety  Part V: Benefit-Risk Assessment of Vaccination Programmes  21.Benefit-risk assessment of vaccination programmes

Biography

Susan Hahné is a senior epidemiologist in the National Immunisation Programme Department at the Centre for Epidemiology and Surveillance of Infectious Diseases of the National Institute for Public Health and the Environment (RIVM) in the Netherlands.

Kaatje Bollaerts is the head of data science at P95 Belgium, a scientific service-providing company focused on pharmacovigilance and epidemiology related to vaccines and infectious diseases.

Paddy Farrington is an emeritus professor of statistics at the Open University (OU), UK. Prior to joining the OU in 1998, he was a statistician at the Immunisation Division of the Communicable Disease Surveillance Centre in the UK for 11 years